ArticleJournal of neuro-oncology2009

Molecular properties of CD133+ glioblastoma stem cells derived from treatment-refractory recurrent brain tumors.

Qinghai Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.